GENERATIVE BIOLOGY Trademark

Trademark Overview

On Monday, July 6, 2020, a trademark application was filed for GENERATIVE BIOLOGY with the United States Patent and Trademark Office. The USPTO has given the GENERATIVE BIOLOGY trademark a serial number of 90037397. The federal status of this trademark filing is REGISTERED as of Tuesday, December 7, 2021. This trademark is owned by Generate Biomedicines, Inc.. The GENERATIVE BIOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development in the field of biotechnology, protein engineering, and development of pharmaceuticals; custom development of proteins, and chemical and biological agents; technical scientific consultation and product development in the field of proteins, biotechnology and development of pharmaceuticals; research and development and consultation related thereto in the field of biotechnology, protein engineering, and development of pharmaceuticals
generative biology

General Information

Serial Number90037397
Word MarkGENERATIVE BIOLOGY
Filing DateMonday, July 6, 2020
Status700 - REGISTERED
Status DateTuesday, December 7, 2021
Registration Number6585094
Registration DateTuesday, December 7, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development in the field of biotechnology, protein engineering, and development of pharmaceuticals; custom development of proteins, and chemical and biological agents; technical scientific consultation and product development in the field of proteins, biotechnology and development of pharmaceuticals; research and development and consultation related thereto in the field of biotechnology, protein engineering, and development of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 3, 2020
Primary Code042
First Use Anywhere DateMonday, August 31, 2020
First Use In Commerce DateMonday, August 31, 2020

Trademark Owner History

Party NameGenerate Biomedicines, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenerate Biomedicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, November 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 7, 2021REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, November 2, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 26, 2021ASSIGNED TO LIE
Tuesday, October 26, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, October 25, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, October 25, 2021USE AMENDMENT ACCEPTED
Friday, October 22, 2021AMENDMENT TO USE PROCESSING COMPLETE
Friday, October 22, 2021USE AMENDMENT FILED
Thursday, October 21, 2021TEAS AMENDMENT OF USE RECEIVED
Thursday, October 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 21, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 21, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 21, 2021FINAL REFUSAL E-MAILED
Wednesday, April 21, 2021FINAL REFUSAL WRITTEN
Thursday, April 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 15, 2020NON-FINAL ACTION E-MAILED
Thursday, October 15, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 13, 2020ASSIGNED TO EXAMINER
Monday, August 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

biology generative development research field pharmaceuticals scientific biotechnology consultation product proteins engineering